Editorial Material
Hematology
Alan H. Lazarus, John W. Semple
Summary: A study found that patients with chronic ITP have clonal expansions of a specific subset of CD8 T cells called terminally differentiated effector memory (TEMRA) T cells. These cells persist over the course of the disease, are more prominent in refractory ITP, and are more prevalent when the platelet count is low.
Article
Multidisciplinary Sciences
Giacomo Oliveira, Kari Stromhaug, Susan Klaeger, Tomasz Kula, Dennie T. Frederick, Phuong M. Le, Juliet Forman, Teddy Huang, Shuqiang Li, Wandi Zhang, Qikai Xu, Nicoletta Cieri, Karl R. Clauser, Sachet A. Shukla, Donna Neuberg, Sune Justesen, Gavin MacBeath, Steven A. Carr, Edward F. Fritsch, Nir Hacohen, Moshe Sade-Feldman, Kenneth J. Livak, Genevieve M. Boland, Patrick A. Ott, Derin B. Keskin, Catherine J. Wu
Summary: The authors demonstrate through single-cell profiling and T cell receptor specificity screening that tumour antigen recognition influences the phenotypes of CD8(+) T cells and antitumour immune responses. Non-tumour-reactive T cells show a non-exhausted memory phenotype, while melanoma-reactive lymphocytes exhibit an exhausted state, providing insights into the properties of the anti-melanoma TCR repertoire.
Article
Immunology
Emil Lagumdzic, Clara Pernold, Marta Viano, Simone Olgiati, Michael W. Schmitt, Kerstin H. Mair, Armin Saalmueller
Summary: Pigs have the potential to be a valuable research model for studying human diseases, pharmacology, and transplantation. This study aimed to better understand the porcine immune system by analyzing the transcriptomes of different subsets of porcine CD8(+) T cells. The results showed distinct gene expression patterns in different subsets, providing valuable information for further research on porcine immune cell subsets.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Immunology
Chuan Li, Yee Peng Phoon, Keaton Karlinsey, Ye F. Tian, Samjhana Thapaliya, Angkana Thongkum, Lili Qu, Alyssa Joyce Matz, Mark Cameron, Cheryl Cameron, Antoine Menoret, Pauline Funchain, Jung-Min Song, C. Marcela Diaz-Montero, Banumathi Tamilselvan, Jackelyn B. Golden, Michael Cartwright, Annabelle Rodriguez, Christopher Bonin, Anthony Vella, Beiyan Zhou, Brian R. Gastman
Summary: Single-cell transcriptomics revealed a subset of CD8 T cells with high oxidative phosphorylation in melanoma patients, which correlated with immune checkpoint inhibitor resistance. A predictive model based on transcriptomic profiles of these cells accurately distinguished responders from nonresponders, offering potential as a new target for improving outcomes in melanoma patients.
JOURNAL OF EXPERIMENTAL MEDICINE
(2021)
Article
Biotechnology & Applied Microbiology
Romain Ballet, Melissa Lajevic, Noelle Huskey-Mullin, Rachel Roach, Kevin Brulois, Ying Huang, Muhammad A. Saeed, Ha X. Dang, Russell K. Pachynski, Elizabeth Wilson, Eugene C. Butcher, Brian A. Zabel
Summary: This study reveals the role of chemerin:CMKLR1 in defining a specialized NK-like CD8 T cell and suggests the use of chemerin-dependent modalities to target effector CMKLR1-expressing T cells to the tumor microenvironment for immunotherapeutic purposes. In an experimental prostate tumor mouse model, chemerin expression is downregulated in the tumor microenvironment, which is associated with few tumor-infiltrating CD8+ T cells.
Article
Medicine, General & Internal
Hoa Le Mai, Nicolas Degauque, Sabine Le Bot, Marie Rimbert, Karine Renaudin, Richard Danger, Florent Le Borgne, Clarisse Kerleau, Gaelle Tilly, Anais Vivet, Florent Delbos, Alexandre Walencik, Magali Giral, Sophie Brouard
Summary: The study found that the percentage and absolute number of CD28-CD8+ T cells were significantly increased in kidney transplant patients with antibody-mediated rejection (ABMR). Moreover, CD28-CD8+ T cells from patients with ABMR showed a more rigorous response to stimulation compared to their CD28+ counterparts. These findings suggest that differentiated CD28-CD8+ T cells, with increased frequency, number, and function, may play a role in the pathobiology of ABMR.
Article
Immunology
Aleksey K. Molodtsov, Nikhil Khatwani, Jennifer L. Vella, Kathryn A. Lewis, Yanding Zhao, Jichang Han, Delaney E. Sullivan, Tyler G. Searles, Nicholas K. Preiss, Tamer B. Shabaneh, Peisheng Zhang, Aaron R. Hawkes, Brian T. Malik, Fred W. Kolling, Edward J. Usherwood, Sandra L. Wong, Joseph D. Phillips, Keisuke Shirai, Christina Angeles, Shaofeng Yan, Tyler J. Curiel, Yina H. Huang, Chao Cheng, Mary Jo Turk
Summary: The study revealed that tumor-specific Trm cells persist in lymph nodes, restraining the development of metastatic cancer and providing long-term protection against melanoma seeding. These findings suggest that Trm cells play a crucial role in preventing the spread of melanoma.
Article
Agriculture, Dairy & Animal Science
Sangwook Kim, Byeonghwi Lim, Sameer-ul-Salam Mattoo, Eun-Young Oh, Chang-Gi Jeong, Won-Il Kim, Kyung-Tai Lee, Sang-Myeong Lee, Jun-Mo Kim
Summary: This study comprehensively investigated the functional mechanisms of CD8(+/-) porcine gamma delta T cells related to the immune system using RNA-sequencing technology. The upregulated DEGs were enriched in cytokine-cytokine receptor interaction and TCR signaling pathway, while the downregulated DEGs were enriched in B cell receptor signaling pathway, suggesting potential immune regulatory roles for these genes. The identified genes, such as chemokine-related and IFNG, in the pathways may play a crucial role in immune signaling inter-regulation.
Article
Biochemistry & Molecular Biology
Valentina Tedeschi, Giorgia Paldino, Martina Kunkl, Marino Paroli, Rosa Sorrentino, Loretta Tuosto, Maria Teresa Fiorillo
Summary: CD8(+) T lymphocytes play a crucial role in immune response, but aging and disease can alter their function and phenotype, impacting vaccine and treatment strategies.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Immunology
Ziyan Shi, Xiaofei Wang, Jiancheng Wang, Hongxi Chen, Qin Du, Yanlin Lang, Lingyao Kong, Wenqin Luo, Yuhan Qiu, Ying Zhang, Chen Li, Dingke Wen, Jie Yao, Xia Cheng, Linjun Cai, Xue Lin, Rui Wang, Zichao Mou, Shuangjie Li, Duanya Liu, Hong Zhou, Hongyu Zhou, Mu Yang
Summary: This study investigated the contribution of peripheral CD8+ T cells during the conversion from RRMS to SPMS and revealed a diagnostic biomarker for distinguishing SPMS from RRMS. Single-cell RNA sequencing and flow cytometry were used to analyze the heterogeneity and dynamic changes of CD8+ T cells. The study found that activated CD8+ T cell subsets were elevated in SPMS patients, and GzmB expression in CD8+ T-EMRA cells played a key role in the progression of MS. The expression of GzmB in CD8+ T cells was correlated with disability and progression of MS, and could effectively distinguish SPMS from RRMS.
JOURNAL OF NEUROINFLAMMATION
(2023)
Article
Multidisciplinary Sciences
Yuka Nakajima, Kenji Chamoto, Takuma Oura, Tasuku Honjo
Summary: CD8(+) T cells play a crucial role in antitumor immune responses, but this function is suppressed in aged individuals. The mechanism of this age-related immune decline is unclear. This study found that inefficient generation of a specific CD8(+) T cell subset may contribute to age-related resistance to PD-1 blockade, which can be overcome by strong TCR stimulation.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2021)
Article
Multidisciplinary Sciences
Zijun Wang, Mou Peng
Summary: LCP2 expression is upregulated in metastatic skin cutaneous melanoma and associated with good overall survival. It is involved in multiple immune response pathways and positively correlated with molecules in TCR signaling and immune checkpoints in melanoma. High LCP2 expression is positively correlated with tumor-infiltrating CD8(+) T cells and acts as a prognostic biomarker for progression-free survival in patients receiving anti-PD1 immunotherapy.
SCIENTIFIC REPORTS
(2021)
Article
Oncology
Kavitha Yaddanapudi, Bryce F. Stamp, Priyanka B. Subrahmanyam, Andrei Smolenkov, Sabine J. Waigel, Rahul Gosain, Michael E. Egger, Robert C. G. Martin, Robert Buscaglia, Holden T. Maecker, Kelly M. McMasters, Jason A. Chesney
Summary: The study identified immunologic changes in the sentinel lymph nodes of melanoma patients that may impact melanoma treatment. These changes include a potential activation of immune response, as well as a decrease in NK cells and an increase in cells with low melanoma killing capabilities.
CLINICAL CANCER RESEARCH
(2022)
Article
Oncology
Antonino A. A. Pane, Theresa Kordass, Agnes Hotz-Wagenblatt, Elke Dickes, Annette Kopp-Schneider, Rainer Will, Barbara Seliger, Wolfram Osen, Stefan B. B. Eichmueller
Summary: This study identified several miRNA species that can affect the susceptibility of melanoma cells to T cell-mediated killing. These miRNAs may represent attractive candidates for novel therapy approaches against melanoma and other tumors.
CLINICAL AND TRANSLATIONAL MEDICINE
(2023)
Review
Immunology
Keitaro Fukuda
Summary: This article discusses the important role of MSA-specific CD8(+) T cells in the treatment outcomes of melanoma and vitiligo, and explores the key targets for enhancing the efficacy of current therapies and future immunotherapeutic approaches.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Oncology
Lu Huang, Shruti Malu, Jodi A. McKenzie, Miles C. Andrews, Amjad H. Talukder, Trang Tieu, Tatiana Karpinets, Cara Haymaker, Marie-Andree Forget, Leila J. Williams, Zhe Wang, Rina M. Mbofung, Zhi-Qiang Wang, Richard Eric Davis, Roger S. Lo, Jennifer A. Wargo, Michael A. Davies, Chantale Bernatchez, Timothy Heffernan, Rodabe N. Amaria, Anil Korkut, Weiyi Peng, Jason Roszik, Gregory Lizee, Scott E. Woodman, Patrick Hwu
CLINICAL CANCER RESEARCH
(2018)
Article
Multidisciplinary Sciences
Dinler A. Antunes, Didier Devaurs, Mark Moll, Gregory Lizee, Lydia E. Kavraki
SCIENTIFIC REPORTS
(2018)
Article
Multidisciplinary Sciences
Minying Zhang, Jens Fritsche, Jason Roszik, Leila J. Williams, Xinxin Peng, Yulun Chiu, Chih-Chiang Tsou, Franziska Hoffgaard, Valentina Goldfinger, Oliver Schoor, Amjad Talukder, Marie A. Forget, Cara Haymaker, Chantale Bernatchez, Leng Han, Yiu-Huen Tsang, Kathleen Kong, Xiaoyan Xu, Kenneth L. Scott, Harpreet Singh-Jasuja, Greg Lizee, Han Liang, Toni Weinschenk, Gordon B. Mills, Patrick Hwu
NATURE COMMUNICATIONS
(2018)
Article
Oncology
Weiyi Peng, Leila J. Williams, Chunyu Xu, Brenda Melendez, Jodi A. McKenzie, Yuan Chen, Heather L. Jackson, Kui S. Voo, Rina M. Mbofung, Sara Elizabeth Leahey, Jian Wang, Gregory Lizee, Hussein A. Tawbi, Michael A. Davies, Axel Hoos, James Smothers, Roopa Srinivasan, Elaine M. Paul, Niranjan Yanamandra, Patrick Hwu
CLINICAL CANCER RESEARCH
(2019)
Article
Multidisciplinary Sciences
Sherille D. Bradley, Amjad H. Talukder, Ivy Lai, Rebecca Davis, Hector Alvarez, Herve Tiriac, Minying Zhang, Yulun Chiu, Brenda Melendez, Kyle R. Jackson, Arjun Katailiha, Heather M. Sonnemann, Fenge Li, Yaan Kang, Na Qiao, Bih-Fang Pan, Philip L. Lorenzi, Mark Hurd, Elizabeth A. Mittendorf, Christine B. Peterson, Milind Javle, Christopher Bristow, Michael Kim, David A. Tuveson, David Hawke, Scott Kopetz, Robert A. Wolff, Patrick Hwu, Anirban Maitra, Jason Roszik, Cassian Yee, Gregory Lizee
NATURE COMMUNICATIONS
(2020)
Article
Multidisciplinary Sciences
Sayuri Yoshihama, Steven X. Cho, Jason Yeung, Xuedong Pan, Gregory Lizee, Kranti Konganti, Valen E. Johnson, Koichi S. Kobayashi
Summary: The expression of NLRC5 and MHC class I-related genes is crucial for the effective response of melanoma patients to anti-CTLA-4 and anti-PD1 checkpoint blockade immunotherapy, serving as potential predictive biomarkers for prognosis and treatment response.
SCIENTIFIC REPORTS
(2021)
Article
Immunology
Shubhra Singh, Zhilan Xiao, Karishma Bavisi, Jason Roszik, Brenda D. Melendez, Zhiqiang Wang, Mark J. Cantwell, Richard E. Davis, Greg Lizee, Patrick Hwu, Sattva S. Neelapu, Willem W. Overwijk, Manisha Singh
Summary: The study demonstrates that the IL-1 alpha signaling pathway plays a crucial role in melanoma resistance to immunotherapy. Targeting the IL-1 signaling pathway could enhance the efficacy of immunotherapies against melanoma.
JOURNAL OF IMMUNOLOGY
(2021)
Review
Oncology
Ravi G. Gupta, Fenge Li, Jason Roszik, Gregory Lizee
Summary: Immunotherapeutic manipulation targets genomic instability in cancer by activating T cells, but tumors can evade immune recognition through immunoediting and immunosuppressive mechanisms. Challenges in neoantigen-directed therapy include low frequency of immunogenic neoantigens and tumor cell immune evasion mechanisms.
Article
Oncology
Fenge Li, Ligang Deng, Kyle R. Jackson, Amjad H. Talukder, Arjun S. Katailiha, Sherille D. Bradley, Qingwei Zou, Caixia Chen, Chong Huo, Yulun Chiu, Matthew Stair, Weihong Feng, Aleksander Bagaev, Nikita Kotlov, Viktor Svekolkin, Ravshan Ataullakhanov, Natalia Miheecheva, Felix Frenkel, Yaling Wang, Minying Zhang, David Hawke, Ling Han, Shuo Zhou, Yan Zhang, Zhenglu Wang, William K. Decker, Heather M. Sonnemann, Jason Roszik, Marie-Andree Forget, Michael A. Davies, Chantale Bernatchez, Cassian Yee, Roland Bassett, Patrick Hwu, Xueming Du, Gregory Lizee
Summary: The phase I trial of personalized NeoAg peptide vaccination in NSCLC patients showed feasibility and safety. Clinical and immune responses following vaccination suggest that EGFR mutations are shared, immunogenic neoantigens with promising therapeutic potential for NSCLC patients. PPV with concurrent EGFR inhibitor therapy was well tolerated and contributed to the induction of T cell responses.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2021)
Review
Cell Biology
Yimo Sun, Fenge Li, Heather Sonnemann, Kyle R. Jackson, Amjad H. Talukder, Arjun S. Katailiha, Gregory Lizee
Summary: Engineered TCR-T cell therapy has revolutionized the treatment of human cancer by targeting tumor antigen-specific adaptable cellular products. However, challenges such as low TCR avidity, off-target toxicities, and target antigen loss have limited the efficacy of TCR-T therapy for solid tumors. Further research is needed to address these limitations and improve the safety and efficacy of TCR-T therapies.
Article
Oncology
Yared Hailemichael, Daniel H. Johnson, Noha Abdel-Wahab, Wai Chin Foo, Salah-Eddine Bentebibel, May Daher, Cara Haymaker, Khalida Wani, Chantal Saberian, Dai Ogata, Sang T. Kim, Roza Nurieva, Alexander J. Lazar, Hamzah Abu-Sbeih, Faisal Fa'ak, Antony Mathew, Yinghong Wang, Adewunmi Falohun, Van Trinh, Chrystia Zobniw, Christine Spillson, Jared K. Burks, Muhammad Awiwi, Khaled Elsayes, Luisa Solis Soto, Brenda D. Melendez, Michael A. Davies, Jennifer Wargo, Jonathan Curry, Cassian Yee, Gregory Lizee, Shalini Singh, Padmanee Sharma, James P. Allison, Patrick Hwu, Suhendan Ekmekcioglu, Adi Diab
Summary: Immune checkpoint blockade therapy can cause immune-related adverse events. IL-6 expression is higher in colitis and Th17 cells are more prevalent in immune-related enterocolitis. Anti-CTLA-4 induces stronger Th17 memory in colitis than anti-PD-1. In mouse models, IL-6 blockade enhances tumor control and increases CD4(+)/CD8(+) effector T cell density, while reducing Th17, macrophages, and myeloid cells. Combined IL-6 blockade and ICB enhances tumor rejection and mitigates EAE symptoms. IL-6 blockade with ICB can decouple autoimmunity from antitumor immunity.
Article
Oncology
Chantal Saberian, Rodabe N. Amaria, Amer M. Najjar, Laszlo G. Radvanyi, Cara L. Haymaker, Marie-Andree Forget, Roland L. Bassett, Silvana C. Faria, Isabella C. Glitza, Enrique Alvarez, Sapna Parshottam, Victor Prieto, Gregory Lizee, Michael K. Wong, Jennifer L. McQuade, Adi Diab, Cassian Yee, Hussein A. Tawbi, Sapna Patel, Elizabeth J. Shpall, Michael A. Davies, Patrick Hwu, Chantale Bernatchez
Summary: The combination of adoptive transfer of tumor-infiltrating lymphocytes (TIL) and dendritic cells (DC) did not show significant difference in the persistence of MART-1-specific TIL compared to TIL therapy alone. Although more patients showed clinical response to TIL+DC therapy, the study was not powered to resolve differences between the two groups.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2021)
Article
Multidisciplinary Sciences
Jayvee R. Abella, Dinler Antunes, Kyle Jackson, Gregory Lizee, Cecilia Clementi, Lydia E. Kavraki
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2020)
Article
Oncology
Dinler A. Antunes, Jayvee R. Abella, Sarah Hall-Swan, Didier Devaurs, Anja Conev, Mark Moll, Gregory Lizee, Lydia E. Kavraki
JCO CLINICAL CANCER INFORMATICS
(2020)
Article
Cell Biology
Didier Devaurs, Dinler A. Antunes, Sarah Hall-Swan, Nicole Mitchell, Mark Moll, Gregory Lizee, Lydia E. Kavraki
BMC MOLECULAR AND CELL BIOLOGY
(2019)